TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/18/22 15:56 | 8/17/22 | VTGN | Vistagen Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Singh Shawn | CA | DO | CEO | P | 103 | 0.1720 | 0 | 600 | 333 | 780 | I | ||||||||||||||
5/16/22 13:39 | 5/12/22 | VTGN | Vistagen Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Singh Shawn | CA | DO | CEO | M.d | 100 | 1.00 | 0 | 100 | 133 | 175 | D | ||||||||||||||
4/27/21 16:13 | 4/23/21 | VTGN | Vistagen Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Singh Shawn | CA | DO | CEO | M.d | 8 | 1.50 | 0 | 5 | 8 | 67 | D | ||||||||||||||
1/15/19 16:29 | 1/14/19 | VTGN | Vistagen Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Singh Shawn | CA | DO | CEO | M.d | 38 | 1.50 | 0 | 25 | 97 | 52 | D | ||||||||||||||
10/15/13 18:20 | 10/15/13 | VSTA | Vistagen Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Singh Shawn | CA | DO | CEO | M.d | 6 | 0.6400 | 0 | 10 | 3 | 312 | I | ||||||||||||||
6/27/13 15:39 | 6/27/13 | VSTA | Vistagen Therapeutics, Inc. | NV | Health | Drug | Pharmaceutical Preparations | Singh Shawn | CA | DO | CEO | M.d | 32 | 0.6400 | 0 | 50 | 20 | 302 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |